GlassScriptPhysician profile
Armando Alvarez
NPI 1568969293
$6,176.86
in general payments reported to CMS, 2019-2025
19 companies · $938 in 2025
The $938 reported for 2025 was more than what 87% of Physical Medicine & Rehabilitation providers received nationally (typical 2025 total: $138).
See the full distribution for Physical Medicine & Rehabilitation
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $67.49 · 2022: $23.86 · 2023: $1,261 · 2024: $3,887 · 2025: $938.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $4,054 · Travel and Lodging: $2,032.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $4,053.66 |
| Travel and Lodging | $2,031.85 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbott Laboratories | $2,042.80 | 2023-2025 | Proclaim, Prodigy, Eterna |
| Curonix LLC | $937.87 | 2023-2024 | Pns Freedom-4a Permanent Neurostimulator Receiver Kit Channel A |
| Medtronic, INC. | $698.96 | 2023-2024 | Intellis Adaptivestim, Kyphon Express II Kyphopak Tray |
| Saluda Medical Americas, INC. | $508.69 | 2024 | Evoke |
| Spr Therapeutics, INC | $429.86 | 2023-2025 | Sprint Pns System |
| Nevro Corp. | $302.22 | 2023-2024 | Senza |
| Boston Scientific Corporation | $274.37 | 2023-2024 | Intracept, Wavewriter Alpha Prime 16 |
| Globus Medical, INC. | $243.83 | 2025 | Senza |
| Stryker Corporation | $160.00 | 2024 | Optablate |
| Gilead Sciences, INC. | $153.19 | 2024-2025 | Biktarvy |
| Vertex Pharmaceuticals Incorporated | $144.46 | 2025 | |
| Biogen, INC. | $63.80 | 2025 | Vumerity, Tysabri |
| Saol Therapeutics INC. | $47.78 | 2021 | |
| Abbvie INC. | $42.02 | 2022-2025 | |
| Averitas Pharma INC. | $39.22 | 2025 | Qutenza |
Show all 19 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Emd Serono, INC. | $27.57 | 2025 | |
| Napo Pharmaceuticals INC | $21.32 | 2024 | Mytesi |
| Allergan, INC. | $19.71 | 2021 | |
| Mallinckrodt Hospital Products INC. | $19.19 | 2025 | Acthar |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Armando Alvarez listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.